VVelarionINTELLIGENCE
Sign inStart free trial
Start free trial
MedTech & Diagnostics

HCA Healthcare Executive Compensation (FY25)

HCA · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Samuel Hazen
Latest say-on-pay support
=
April 23, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
See every company’s exec pay — free for 3 days, no cardSee the plan and pricing

The HCA Healthcare brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
Get the executive briefGet the board briefNo account needed.
Data as of November 5, 2026Latest filing (8-K): April 28, 2026
13 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
HCA Healthcare brief$500Get the executive brief
Velarion Intel, one year, every company
304 figures on this page: 295 cited to the filing that reported them, 9 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Samuel Hazen: $23,799,137 → $26,456,606 (11.2% higher)
Say-on-pay support: 93.6% → 93.5% (0.1 points lower)
CEO pay ratio: 356:1 → 420:1 (18.0% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is HCA Healthcare's chief executive and what were they paid?
Samuel Hazen was paid $26,456,606 in total compensation as Chief Executive Officer for fiscal 2025. Compared with the $23,799,137 reported for fiscal 2024, Hazen's total was 11.2% higher.
What was HCA Healthcare's say-on-pay result?
Shareholders supported the say-on-pay proposal with 93.5% of votes cast for or against in favor at the meeting held April 23, 2026 for fiscal 2025.
Which companies are in HCA Healthcare's peer group?
The disclosed peer group includes Abbott Laboratories, AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Company and Cardinal Health, Inc., among others.
What is HCA Healthcare's chief executive pay ratio?
The company reported a chief executive pay ratio of 420:1 for fiscal 2025, against median employee compensation of $62,955.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Samuel Hazen
Chief Executive Officer
◇—◇◇◇—◇◇
Michael McAlevey
Senior Vice President and Chief Legal Officer
◇◇◇◇◇—◇◇
William Rutherford
Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Charles Hall
President — National Group
◇—◇◇◇◇◇◇
Jon Foster
Executive Vice President and Chief Operating Officer
◇—◇◇◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Samuel Hazen
Chief Executive Officer
◇—◇◇◇—◇◇
Jon Foster
Executive Vice President and Chief Operating Officer
◇—◇◇◇◇◇◇
William Rutherford
Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Timothy McManus
President — National Group
◇—◇◇◇—◇◇
Erol Akdamar
President — American Group
◇—◇◇◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Samuel Hazen
Chief Executive Officer
◇—◇◇◇◇◇◇
Michael Marks
Executive Vice President and Chief Operating Officer
◇—◇◇◇—◇◇
William Rutherford
Executive Vice President and Chief Financial Officer
◇—◇◇——◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Samuel Hazen
Chief Executive Officer
◇—◇◇◇◇◇◇
Jon Foster
Executive Vice President and Chief Operating Officer
◇—◇◇◇◇◇◇
Michael Marks
Executive Vice President and Chief Financial Officer
◇—◇◇◇◇◇◇
Michael McAlevey
Executive Vice President - Chief Legal and Administrative Officer
◇—◇◇◇—◇◇
Michael Cuffe
Executive Vice President and Chief Clinical Officer
◇—◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Jon M. FosterPSU◇◇◇—◇—◇
Jon M. FosterOPTION◇——◇—◇◇
Michael A. MarksPSU◇◇◇—◇—◇
Michael A. MarksOPTION◇——◇—◇◇
Michael R. McAleveyOPTION◇——◇—◇◇
Michael R. McAleveyPSU◇◇◇—◇—◇
Michael S. CuffePSU◇◇◇—◇—◇
Michael S. CuffeOPTION◇——◇—◇◇
Samuel N. HazenPSU◇◇◇—◇—◇
Samuel N. HazenOPTION◇——◇—◇◇
Fiscal 2022, 2023 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Samuel HazenSAR◇—◇1/28/2035
SAR◇—◇1/31/2034
SAR◇—◇1/30/2033
PSU◇◇——
PSU◇◇——
SAR◇—◇1/28/2032
Jon FosterSAR◇—◇1/28/2035
SAR◇—◇1/31/2034
SAR◇—◇1/30/2033
PSU◇◇——
PSU◇◇——
SAR◇—◇1/28/2032
Michael MarksSAR◇—◇1/28/2035
SAR◇—◇4/29/2034
PSU◇◇——
SAR◇—◇1/31/2034
SAR◇—◇1/30/2033
PSU◇◇——
PSU◇◇——
SAR◇—◇1/28/2032
Michael CuffeSAR◇—◇1/28/2035
SAR◇—◇1/31/2034
SAR◇—◇1/30/2033
PSU◇◇——
PSU◇◇——
SAR◇—◇1/28/2032
Michael McAleveySAR◇—◇1/28/2035
SAR◇—◇1/31/2034
SAR◇—◇1/30/2033
PSU◇◇——
PSU◇◇——
SAR◇—◇1/28/2032
SAR◇—◇4/29/2034
PSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Thomas F. Frist III
Board chair
◇◇————◇
Michael W. Michelson
◇◇————◇
Hugh F. Johnston
◇◇————◇
Wayne J. Riley, M.D
◇◇————◇
Andrea B. Smith
◇◇————◇
Nancy-Ann DeParle
◇◇————◇
Robert J. Dennis
◇◇————◇
William R. Frist
◇◇————◇
John W. Chidsey, III
◇◇————◇
Meg G. Crofton
◇—————◇
Samuel N. Hazen served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Lead independent director premium◇
Audit committee chair◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Abbott Laboratories ABT
  • AbbVie Inc. ABBV
  • Amgen Inc. AMGN
  • Bristol-Myers Squibb Company BMY
  • Cardinal Health, Inc. CAH
  • Cencora, Inc. COR
  • Centene Corp. CNC
  • CVS Health Corporation CVS
  • Danaher Corporation DHR
  • Elevance Health, Inc. ELV
  • Eli Lilly and Company LLY
  • Gilead Sciences, Inc. GILD
  • Humana Inc. HUM
  • Johnson & Johnson JNJ
  • McKesson Corporation MCK
  • Medtronic Inc. MDT
  • Merck & Co., Inc. MRK
  • Molina Healthcare, Inc. MOH
  • Pfizer Inc. PFE
  • Stryker Corporation SYK
  • Tenet Healthcare Corporation THC
  • The Cigna Group CI
  • Thermo Fisher Scientific Inc. TMO
  • UnitedHealth Group Incorporated UNH

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025April 23, 2026=◇◇◇
2024April 24, 2025=◇◇◇
2023April 25, 2024=◇◇◇
2022April 19, 2023=◇◇◇
2021April 21, 2022=◇◇◇
2020April 28, 2021=◇◇◇
2019May 1, 2020=◇◇◇
2018April 26, 2019=◇◇◇
2017April 26, 2018=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Samuel Hazen (Chief Executive Officer), FY2025 total compensation $26,456,606 (base salary $1,577,815) [exec_comp, SEC accession 0001193125-26-106142, filed 2026-03-13]

See a complete sample report

Answered within 24 hours, every figure cited to its SEC filing. This is a one-off report: no refunds.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when HCA Healthcare files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact HCA Healthcare disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where HCA Healthcare sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether HCA Healthcare's disclosed peer group is defensible, who names HCA Healthcare back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
304 figures on this page: 295 cited to the filing that reported them, 9 calculated from figures it prints.
295 cited to the filing
9 calculated from the filing

Documents cited

  1. 0001193125-26-187155
  2. 0001193125-26-106142
    2025 Grants of Plan-Based Awards · 2025 Summary Compensation Table · CEO Pay Ratio · Director Compensation. · and 2 more sections
  3. 0001193125-25-103953
  4. 0001193125-25-054832
    Summary Compensation Table
  5. 0001193125-24-125204
  6. 0001193125-24-069180
    2023 Summary Compensation Table
  7. 0001193125-23-110578
  8. 0001193125-23-067645
    2022 Summary Compensation Table
  9. 0001193125-22-120439
  10. 0001193125-21-150111
  11. 0001193125-20-135015
  12. 0001193125-19-135052
  13. 0001193125-18-148854
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “HCA Healthcare executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/HCA (accessed 2026).
Short form: data: Velarion

The HCA Healthcare brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
Get the executive briefGet the board briefNo account needed.
13 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about HCA Healthcare and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers HCA Healthcare discloses

The companies named in HCA's own disclosed peer group.

Abbott LaboratoriesAbbVie Inc.Amgen Inc.Bristol-Myers Squibb CompanyCardinal Health, Inc.Cencora, Inc.Centene Corp.CVS Health CorporationDanaher CorporationElevance Health, Inc.Eli Lilly and CompanyGilead Sciences, Inc.Humana Inc.Johnson & JohnsonMcKesson CorporationMedtronic Inc.Merck & Co., Inc.Molina Healthcare, Inc.Pfizer Inc.Stryker CorporationTenet Healthcare CorporationThe Cigna GroupThermo Fisher Scientific Inc.UnitedHealth Group Incorporated

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy